<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05100667</url>
  </required_header>
  <id_info>
    <org_study_id>796</org_study_id>
    <nct_id>NCT05100667</nct_id>
  </id_info>
  <brief_title>A Potential Role for Oxygen in the Development of Mental Fatigue and the Subsequent Decline in Cognitive Performance</brief_title>
  <official_title>A Potential Role for Oxygen in the Development of Mental Fatigue and the Subsequent Decline in Cognitive Performance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vrije Universiteit Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vrije Universiteit Brussel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction Both Mental Fatigue (MF) and hypoxia impair multiple aspects of cognitive&#xD;
      functioning. The decline in cognitive functioning in hypoxic conditions is associated with&#xD;
      alterations in brain oxygenation and hemodynamic responses. These hemodynamic responses are&#xD;
      preferably measured at the prefrontal cortex, an area of the brain that is known for its&#xD;
      executive function and role in decision making, planning, attention and (short-term) memory.&#xD;
      This study will investigate the role of prefrontal cortex oxygenation during the development&#xD;
      of mental fatigue and during cognitive performances by altering the ambient oxygen&#xD;
      availability through normobaric hypoxia (3800m; 12,9% O2) and normoxia.&#xD;
&#xD;
      Methods Subjects will perform four trials in a sound-insulated climate chamber (20Â°C and 40%&#xD;
      RH). Upon entry in the climatic chamber participants will adapt to the environment for 30&#xD;
      minutes. Next, they will perform a modified cognitive test battery &quot;cognition&quot;, a fine motor&#xD;
      task &quot;Motor Performance Series&quot; and a visuomotor-fitlight task before and after a 60-minute&#xD;
      individualized Stroop task or control task (randomized. blinded, placebo controlled,&#xD;
      counter-balanced, cross-over design). Nearinfrared spectroscopy (NIRS) will be used to assess&#xD;
      hemodynamic changes (oxygenated hemoglobin (O2Hb), deoxygenated-hemoglobin (HHb) and total&#xD;
      hemoglobin (tHb)) at the PFC.&#xD;
&#xD;
      Hypotheses 1) MF will lead to earlier changes in the prefrontal NIRS-parameters (O2Hb, HHb,&#xD;
      tHb) with lower oxygen availability. 2) The effects of MF on cognitive performance manifest&#xD;
      itself to a greater extent with lower oxygen availability.3) Visuomotor performance declines&#xD;
      to a greater extent due to MF with lower oxygen availability.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>randomized blinded placebo-controlled counterbalanced crossover design</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>We will inform the participants in a way that explains the study as an investigation about the influence of different cognitive tasks on a subsequent physical task at various altitudes looking at other physiological outcome measures.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebral oxygenation</measure>
    <time_frame>2 hours</time_frame>
    <description>Prefrontal cortex oxygenation = relative changes in oxy- and deoxy hemoglobin at the prefrontal cortex. During the whole frame, participants are equipped with a Near Infrared Spectroscopy device that measures cerebral oxygenation continuously at 10hz.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mental fatigue</measure>
    <time_frame>60 minutes</time_frame>
    <description>Results of a visual analogue scale for mental fatigue</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognition</measure>
    <time_frame>20 minutes</time_frame>
    <description>Results of the Joggle cognition test battery (accuracy and reaction time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fine motor control</measure>
    <time_frame>5 minutes</time_frame>
    <description>Results of the vienna test system (MLS) =accuraccy and reaction time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visuomotor control</measure>
    <time_frame>7 minutes</time_frame>
    <description>Results of a visuomotor fitlight task = accuracy and reaction time</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Hemoglobin concentration</measure>
    <time_frame>10 minutes</time_frame>
    <description>Hemoglobin will be assessed through the analysys of 1 drop of arterial blood</description>
  </other_outcome>
  <other_outcome>
    <measure>Blood glucose concentration</measure>
    <time_frame>10 minutes</time_frame>
    <description>Hemoglobin will be assessed through the analysys of 1 drop of arterial blood</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Mental Fatigue</condition>
  <condition>Near Infrared Spectroscopy</condition>
  <condition>NIRS</condition>
  <condition>Hypoxia</condition>
  <condition>Cerebral Heamodynamics</condition>
  <condition>Cognition</condition>
  <arm_group>
    <arm_group_label>Mental fatigue</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Stroop task</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control MF</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Emotionally neutral documentary</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypoxia</intervention_name>
    <description>altitude (3800m)</description>
    <arm_group_label>Control MF</arm_group_label>
    <arm_group_label>Mental fatigue</arm_group_label>
    <other_name>Mental fatigue</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normoxia</intervention_name>
    <description>sea level</description>
    <arm_group_label>Control MF</arm_group_label>
    <arm_group_label>Mental fatigue</arm_group_label>
    <other_name>Mental fatigue</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy (No neurological or cardiovascular disorders)&#xD;
&#xD;
          -  Male or female&#xD;
&#xD;
          -  No medication&#xD;
&#xD;
          -  Non-smoker&#xD;
&#xD;
          -  Between 18 and 35 years old&#xD;
&#xD;
          -  Recreational athlete population; performance level 2 or 3 for men according to De Pauw&#xD;
             et al. (2013)[29] and performance level 2 or 3 for woman according to Decroix et al.&#xD;
             (2015)&#xD;
&#xD;
          -  Non-acclimatized to altitude (at least 2 months)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Injuries&#xD;
&#xD;
          -  Acclimated to altitude&#xD;
&#xD;
          -  Use of medication&#xD;
&#xD;
          -  Use of caffeine and heavy efforts 24 hours prior each trial&#xD;
&#xD;
          -  Not eating a standardized meal, the morning of each trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Human Physiology - MFYS</name>
      <address>
        <city>Brussel</city>
        <state>Brussels</state>
        <zip>1050</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonas De Wachter, MSc</last_name>
      <phone>026292707</phone>
      <email>jonas.de.wachter@vub.be</email>
    </contact>
    <contact_backup>
      <last_name>Bart Roelands, PhD</last_name>
      <phone>026292707</phone>
      <email>bart.roelands@vub.be</email>
    </contact_backup>
    <investigator>
      <last_name>Jonas De Wachter, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthias Proost, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bart Roelands, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeroen Van Cutsem, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Human Physiology - MFYS</name>
      <address>
        <city>Brussels</city>
        <zip>1050</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonas De Wachter, MsC</last_name>
      <phone>026292707</phone>
      <email>jonas.de.wachter@vub.be</email>
    </contact>
    <investigator>
      <last_name>Jonas De Wachter, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 28, 2021</study_first_submitted>
  <study_first_submitted_qc>October 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2021</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vrije Universiteit Brussel</investigator_affiliation>
    <investigator_full_name>Romain Meeusen</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatigue</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Mental Fatigue</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

